A multidisciplinary study of the management of neuroleptic medication in schizophrenia: Educational and collaborative approaches

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN93636537

Enrollment

228

Registered

2000-10-23

Start date

1995-06-01

Completion date

Unknown

Last updated

2020-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia Mental and Behavioural Disorders Schizophrenia

Interventions

1. Compliance intervention (patients educated about benefits of neuroleptic medication) 2. Alliance intervention (structured intervention in which patients are encouraged to rationally

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients suffering from Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) schizophrenia or schizoaffective disorder admitted to acute psychiatric wards in the North West of England and North Wales.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
1. Attitudes towards neuroleptic medication as measured by the Drug Attitudes Inventory 2. Psychotic symptoms as measured by the Positive and Negative Syndromes Scale	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026